相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Determinants of denervation-independent depletion of putamen dopamine in Parkinson's disease and multiple system atrophy
David S. Goldstein et al.
PARKINSONISM & RELATED DISORDERS (2017)
DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function
N. Plotegher et al.
SCIENTIFIC REPORTS (2017)
Neuronal Glutathione Content and Antioxidant Capacity can be Normalized In Situ by N-acetyl Cysteine Concentrations Attained in Human Cerebrospinal Fluid
Reno C. Reyes et al.
NEUROTHERAPEUTICS (2016)
Detection of Free and Protein-Bound ortho-Quinones by Near-Infrared Fluorescence
Joseph R. Mazzulli et al.
ANALYTICAL CHEMISTRY (2016)
Effervescent N-Acetylcysteine Tablets versus Oral Solution N-Acetylcysteine in Fasting Healthy Adults: An Open-Label, Randomized, Single-Dose, Crossover, Relative Bioavailability Study
Spencer C. Greene et al.
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL (2016)
3,4-Dihydroxyphenylethanol (Hydroxytyrosol) Mitigates the Increase in Spontaneous Oxidation of Dopamine During Monoamine Oxidase Inhibition in PC12 Cells
David S. Goldstein et al.
NEUROCHEMICAL RESEARCH (2016)
Elevated cerebrospinal fluid ratios of cysteinyl-dopamine/3,4-dihydroxyphenylacetic acid in parkinsonian synucleinopathies
David S. Goldstein et al.
PARKINSONISM & RELATED DISORDERS (2016)
N-Acetyl Cysteine May Support Dopamine Neurons in Parkinson's Disease: Preliminary Clinical and Cell Line Data
Daniel A. Monti et al.
PLOS ONE (2016)
Comparison of Monoamine Oxidase Inhibitors in Decreasing Production of the Autotoxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde in PC12 Cells
David S. Goldstein et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
N-acetylcysteine prevents rotenone-induced Parkinson's disease in rat: An investigation into the interaction of parkin and Drp1 proteins
Arman Rahimmi et al.
BRAIN RESEARCH BULLETIN (2015)
Oligomerization and Membrane-binding Properties of Covalent Adducts Formed by the Interaction of α-Synuclein with the Toxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde (DOPAL)
Cristian Follmer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Rotenone decreases intracellular aldehyde dehydrogenase activity: implications for the pathogenesis of Parkinson's disease
David S. Goldstein et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review
Deepmala et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2015)
Cerebrospinal fluid concentrations of N-acetylcysteine after oral administration in Parkinson's disease
Maya Katz et al.
PARKINSONISM & RELATED DISORDERS (2015)
Evidence that Formulations of the Selective MAO-B Inhibitor, Selegiline, which Bypass First-Pass Metabolism, also Inhibit MAO-A in the Human Brain
Joanna S. Fowler et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disorders
David S. Goldstein et al.
PHARMACOLOGY & THERAPEUTICS (2014)
N-acetylcysteine Boosts Brain and Blood Glutathione in Gaucher and Parkinson Diseases
Mary J. Holmay et al.
CLINICAL NEUROPHARMACOLOGY (2013)
Human absorption and metabolism of oleuropein and hydroxytyrosol ingested as olive (Olea europaea L.) leaf extract
Martin de Bock et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2013)
Glutathione depletion and overproduction both initiate degeneration of nigral dopaminergic neurons
Manuel Garrido et al.
ACTA NEUROPATHOLOGICA (2011)
Mitochondrial dysfunction mediated by quinone oxidation products of dopamine: Implications in dopamine cytotoxicity and pathogenesis of Parkinson's disease
Sirsendu Jana et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
In vivo demonstration that α-synuclein oligomers are toxic
Beate Winner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The Neurotoxicity of DOPAL: Behavioral and Stereological Evidence for Its Role in Parkinson Disease Pathogenesis
W. Michael Panneton et al.
PLOS ONE (2010)
Cytotoxicity of dopaminochrome in the mesencephalic cell line, MN9D, is dependent upon oxidative stress
Andrew J. Linsenbardt et al.
NEUROTOXICOLOGY (2009)
Bioavailability of olive oil phenolic compounds in humans
R. de la Torre
INFLAMMOPHARMACOLOGY (2008)
Antioxidative and anti-inflammatory effects of four cysteine-containing agents in striatum of MPTP-treated mice
Chiu-Mei Chen et al.
NUTRITION (2007)
Kinetic and structural analysis of the early oxidation products of dopamine -: Analysis of the interactions with α-synuclein
Marco Bisaglia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Neurotoxicity of MAO metabolites of catecholamine neurotransmitters: Role in neurodegenerative diseases
WJ Burke et al.
NEUROTOXICOLOGY (2004)
Preventive effect of antioxidants in MPTP-induced mouse model of Parkinson's disease
SW Park et al.
NEUROSCIENCE LETTERS (2004)
3,4-dihydroxyphenylacetaldehyde is the toxic dopamine metabolite in vivo: implications for Parkinson's disease pathogenesis
WJ Burke et al.
BRAIN RESEARCH (2003)
3,4-Dihydroxyphenylacetaldehyde: A Potential Target for Neuroprotective Therapy in Parkinson's Disease
W. J. Burke
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2003)
Cytotoxicity of dopamine-derived tetrahydroisoquinolines on melanoma cells
F De Marco et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Major phenolic compounds in olive oil: metabolism and health effects
KL Tuck et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2002)
Catechol ortho-quinones: the electrophilic compounds that form depurinating DNA adducts and could initiate cancer and other diseases
EL Cavalieri et al.
CARCINOGENESIS (2002)
5-S-cysteinyl-conjugates of catecholamines induce cell damage, extensive DNA base modification and increases in caspase-3 activity in neurons
JPE Spencer et al.
JOURNAL OF NEUROCHEMISTRY (2002)
3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells
I Lamensdorf et al.
BRAIN RESEARCH (2000)
Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants:: Potential implication in relation to the pathogenesis of Parkinson's disease
R Soto-Otero et al.
JOURNAL OF NEUROCHEMISTRY (2000)
分享论文
